Search research articles
Contact Us
Filters
Showing results (741-750 of 777) with videos related to
Page
of 78
Sort By:
Hepatology (Baltimore, Md.)
|
February 11, 2021
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
Amaro Taylor-Weiner, Harsha Pokkalla, Ling Han, et al.
Cells
|
October 23, 2021
Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression
Ahmed Ghallab, Maiju Myllys, Adrian Friebel, et al.
Journal of Hepatology
|
February 8, 2022
Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity
Ahmed Ghallab, Reham Hassan, Ute Hofmann, et al.
Journal of Autoimmunity
|
September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be done
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
Annals of the Rheumatic Diseases
|
March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
The New England Journal of Medicine
|
August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Hepatology (Baltimore, Md.)
|
March 11, 2026
Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency
Christina Schrader, Malin Fromme, Paul Ellis, et al.
Nature Medicine
|
August 23, 2011
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Guenter Haemmerle, Tarek Moustafa, Gerald Woelkart, et al.
JHEP Reports : Innovation in Hepatology
|
December 1, 2025
Stage-dependent effects of systemic ASBT inhibition in a cholestasis-induced cholemic nephropathy mouse model
Ahmed Ghallab, Maiju Myllys, Daniela González, et al.
Annals of the Rheumatic Diseases
|
November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Josef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Page
of 78
Search research articles
Search
Showing results (741-750 of 777) with videos related to
Sort By:
Page
of 78
Hepatology (Baltimore, Md.)
|
February 11, 2021
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
Amaro Taylor-Weiner, Harsha Pokkalla, Ling Han, et al.
Cells
|
October 23, 2021
Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression
Ahmed Ghallab, Maiju Myllys, Adrian Friebel, et al.
Journal of Hepatology
|
February 8, 2022
Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity
Ahmed Ghallab, Reham Hassan, Ute Hofmann, et al.
Journal of Autoimmunity
|
September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be done
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
Annals of the Rheumatic Diseases
|
March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
Peter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.
The New England Journal of Medicine
|
August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Hepatology (Baltimore, Md.)
|
March 11, 2026
Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency
Christina Schrader, Malin Fromme, Paul Ellis, et al.
Nature Medicine
|
August 23, 2011
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Guenter Haemmerle, Tarek Moustafa, Gerald Woelkart, et al.
JHEP Reports : Innovation in Hepatology
|
December 1, 2025
Stage-dependent effects of systemic ASBT inhibition in a cholestasis-induced cholemic nephropathy mouse model
Ahmed Ghallab, Maiju Myllys, Daniela González, et al.
Annals of the Rheumatic Diseases
|
November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Josef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Page
of 78